Free Trial

Avantor (AVTR) Expected to Announce Quarterly Earnings on Friday

Avantor logo with Medical background

Avantor (NYSE:AVTR - Get Free Report) is projected to issue its Q2 2025 quarterly earnings data before the market opens on Friday, August 1st. Analysts expect the company to announce earnings of $0.25 per share and revenue of $1.67 billion for the quarter.

Avantor (NYSE:AVTR - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $0.23 EPS for the quarter, meeting the consensus estimate of $0.23. The firm had revenue of $1.58 billion for the quarter, compared to analysts' expectations of $1.61 billion. Avantor had a return on equity of 11.93% and a net margin of 10.70%. The business's quarterly revenue was down 5.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.22 EPS. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Avantor Stock Down 1.7%

NYSE AVTR traded down $0.24 during trading on Monday, hitting $13.97. The stock had a trading volume of 12,246,611 shares, compared to its average volume of 10,740,810. The company has a market capitalization of $9.52 billion, a PE ratio of 13.43, a P/E/G ratio of 1.51 and a beta of 1.05. The company's 50-day moving average price is $13.35 and its two-hundred day moving average price is $15.64. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.75 and a current ratio of 1.12. Avantor has a 12 month low of $11.82 and a 12 month high of $28.00.

Insiders Place Their Bets

In other news, Director Gregory L. Summe acquired 30,000 shares of the firm's stock in a transaction on Friday, May 23rd. The shares were purchased at an average cost of $12.50 per share, with a total value of $375,000.00. Following the acquisition, the director directly owned 100,000 shares in the company, valued at $1,250,000. This represents a 42.86% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Joseph R. Massaro acquired 8,100 shares of the firm's stock in a transaction on Tuesday, April 29th. The stock was purchased at an average cost of $12.30 per share, for a total transaction of $99,630.00. Following the completion of the acquisition, the director owned 35,038 shares in the company, valued at approximately $430,967.40. This represents a 30.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 83,100 shares of company stock worth $1,027,630. Insiders own 1.20% of the company's stock.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Avantor stock. Empowered Funds LLC raised its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 40.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,659 shares of the company's stock after buying an additional 5,075 shares during the quarter. Empowered Funds LLC's holdings in Avantor were worth $286,000 at the end of the most recent reporting period. 95.08% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Wells Fargo & Company cut their target price on Avantor from $25.00 to $22.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Morgan Stanley cut Avantor from an "overweight" rating to an "equal weight" rating in a research note on Tuesday, April 29th. Barclays dropped their price objective on Avantor from $18.00 to $15.00 and set an "overweight" rating on the stock in a research note on Monday, April 28th. The Goldman Sachs Group cut Avantor from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $23.00 to $14.00 in a research note on Tuesday, April 29th. Finally, Royal Bank Of Canada dropped their price objective on Avantor from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, Avantor has a consensus rating of "Hold" and an average target price of $18.23.

Get Our Latest Report on Avantor

Avantor Company Profile

(Get Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Further Reading

Earnings History for Avantor (NYSE:AVTR)

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday
ACT FAST! Congress is Dumping these 3 Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines